Apellis Pharmaceuticals shares owned by Longwood Capital Partners
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Longwood Capital Partners
from 13F filings
Historical chart of Longwood Capital Partners investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Apellis Pharmaceuticals by Longwood Capital Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $9.3M | 245k | 38.04 |
2023-06-30 | $27M | 298k | 91.10 |
2023-03-31 | $19M | 291k | 65.96 |
2022-12-31 | $11M | 218k | 51.71 |
2022-09-30 | $38M | 554k | 68.30 |
2022-06-30 | $25M | 554k | 45.22 |
2022-03-31 | $28M | 554k | 50.81 |
2021-12-31 | $25M | 535k | 47.28 |
2021-09-30 | $2.5M | 76k | 32.95 |
2021-06-30 | $10M | 161k | 63.20 |
2021-03-31 | $4.9M | 113k | 42.91 |
2020-12-31 | $9.6M | 167k | 57.20 |
2020-09-30 | $5.0M | 167k | 30.17 |
2020-06-30 | $6.2M | 190k | 32.66 |
2020-03-31 | $5.6M | 210k | 26.79 |
2019-12-31 | $5.7M | 188k | 30.62 |
2018-06-30 | $3.7M | 168k | 22.00 |